Literature DB >> 28349186

[Surgery for metastatic prostate cancer].

M Fröhner1, M Wirth2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28349186     DOI： 10.1007/s00120-017-0373-9

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  8 in total

Review 1.  Role of salvage lymph node dissection in prostate cancer.

Authors:  Axel Heidenreich; Judd W Moul; Shahrokh Shariat; R Jeffrey Karnes
Journal:  Curr Opin Urol       Date:  2016-11       Impact factor: 2.309

Review 2.  Treatment of bone metastases in urologic malignancies.

Authors:  Michael Froehner; Tobias Hölscher; Oliver W Hakenberg; Manfred P Wirth
Journal:  Urol Int       Date:  2014-08-07       Impact factor: 2.089

Review 3.  Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Marlon Perera; Nathan Papa; Daniel Christidis; David Wetherell; Michael S Hofman; Declan G Murphy; Damien Bolton; Nathan Lawrentschuk
Journal:  Eur Urol       Date:  2016-06-28       Impact factor: 20.096

Review 4.  Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases.

Authors:  Ronak Saluja; Patrick Cheung; Katherine Zukotynski; Urban Emmenegger
Journal:  Urol Oncol       Date:  2016-03-19       Impact factor: 3.498

5.  Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.

Authors:  Tobias Maurer; Gregor Weirich; Margret Schottelius; Martina Weineisen; Benjamin Frisch; Asli Okur; Hubert Kübler; Mark Thalgott; Nassir Navab; Markus Schwaiger; Hans-Jürgen Wester; Jürgen E Gschwend; Matthias Eiber
Journal:  Eur Urol       Date:  2015-05-06       Impact factor: 20.096

6.  Complete PSA Response Following Stereotactic Ablative Radiotherapy for a Bony Metastasis in the Setting of Castrate-Resistant Prostate Cancer.

Authors:  Jelena Lukovic; George Rodrigues
Journal:  Cureus       Date:  2015-10-26

7.  Cancer-specific and overall survival in patients with recurrent prostate cancer who underwent salvage extended pelvic lymph node dissection.

Authors:  Daniar K Osmonov; Alexey V Aksenov; David Trick; Carsten M Naumann; Moritz F Hamann; Amr Abou Faddan; Klaus-Peter Jünemann
Journal:  BMC Urol       Date:  2016-09-06       Impact factor: 2.264

8.  Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.

Authors:  Nazareno Suardi; Giorgio Gandaglia; Andrea Gallina; Ettore Di Trapani; Vincenzo Scattoni; Damiano Vizziello; Vito Cucchiara; Roberto Bertini; Renzo Colombo; Maria Picchio; Giampiero Giovacchini; Francesco Montorsi; Alberto Briganti
Journal:  Eur Urol       Date:  2014-02-18       Impact factor: 20.096
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.